Montvale, NJ - - March 22, 2007 – Memory Pharmaceuticals Corp. (NASDAQ: MEMY) announced today that David A. Lowe, Ph.D., Chief Scientific Officer, will be presenting at the following upcoming investor conferences:
-
Future Leaders in the Biotech Industry Conference on Thursday, March 29, 2007 at
2:30 p.m. Eastern Time at the Millennium Broadway Hotel in New York City.
-
Leerink Swann & Company/MEDACorp Alzheimer’s Disease Roundtable Conference on
Tuesday, April 3, 2007 at 10:15 a.m. Eastern Time at Le Parker Meridien Hotel
in New York City.
Interested parties may access a live audio webcast of the presentations by visiting the
“Investors” section of Memory Pharmaceuticals’ website at
http://www.memorypharma.com. Archived versions of the webcasts will be
available at the same location for one week following each of the
presentations.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing
innovative drugs for the treatment of debilitating CNS disorders such as
Alzheimer's disease, schizophrenia, depression and bipolar disorder. For
additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
http://www.memorypharma.com/
